Navigation Links
After 18 Months On the U.S. Market, Regeneron's Eylea Captures One-Fifth of First-Line Intravitreal Pharmacotherapy Share Among Wet Age-Related Macular Degeneration (AMD) Patients
Date:7/10/2013

atients, the number of office visits patients have attended or missed in the past year did not differ between Avastin, Eylea or Lucentis," said BioTrends Research Group, Senior Business Insights Analyst Emma Williams, Ph.D. "In addition, no differences were observed between the dosing frequency of the anti-VEGF agents in this patient-level audit."

When presented with profiles of products in development for wet AMD and asked to hypothetically choose one product to switch the audit patient to, Allergan's AGN-150998 (anti-VEGF DARPin) and Ophthotech's Fovista are most frequently chosen, owing to their alternative mechanisms of action, AGN-150998's more convenient administration, and the anticipated synergistic effect of Fovista when administered as adjunctive therapy with an anti-VEGF agent. While no difference exists between candidates and noncandidates in terms of their current anti-VEGF therapy, AGN-150998 candidates are significantly more likely to have been started on their current IVT due to expectations of efficacy in slowing vision loss or efficacy in restoring vision, suggesting that surveyed physicians are optimistic that AGN-150998 may provide a superior effect on vision compared to currently available products.

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please visit www.bio-trends.com. BioTrends is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Reso
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Operating without interrupting warfarin reduces risk of bleeding after cardiac device surgery
2. Street Named After EMCO High Voltage Corporation
3. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
4. Pesticide-Exempt Bed Bug Spray Offered to Public After Bed Bugs Troubled a Lincoln Care Facility, My Cleaning Products Relates How to Get One
5. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
6. Non-Toxic Bed Bug Spray Offers Complimentary Sample to Court After a Man Infected It With Bed Bugs, My Cleaning Products Explains How Others Could Get a Sample
7. New injectable hydrogel encourages regeneration and improves functionality after a heart attack
8. Walking again after spinal injury
9. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2012 On Thursday, February 28, 2013, After Close of U.S.-Based Financial Markets
10. First Effective Treatment For Traumatic Brain Injury Reported by Institute of Neurological Recovery, Even Years After Injury
11. New wave of technologies possible after ground-breaking analysis tool developed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Apache Junction, AZ (PRWEB) June 02, 2015 ... of light microscope technology, Yancy Corporation is ... with any desired material and biological sample, displaying the ... and electron bonds between atoms. , Jeff Porter, Co-Founder ... new physics are just that – rare. They come ...
(Date:6/2/2015)... 2, 2015 MGB Biopharma ... resistance problem  MGB Biopharma, a biopharmaceutical ... to address the major global problem of antibiotic ... stable intravenous (IV) formulation of MGB-BP-3, designed for the ... The intravenous formulation of MGB-BP-3 is ...
(Date:6/2/2015)... June 02, 2015 German-based Moenninghoff has ... States distributor for the Moenninghoff product line . ... am pleased to announce that the R.M. Hoffman Company ... our firm, founded in 1916, this is a strategically ... is the kind of professional distributor we need to ...
(Date:6/2/2015)... Orleans, LA (PRWEB) June 02, 2015 ... custom gene synthesis to improve protein expression, announced the ... board includes six executives and entrepreneurs with a broad ... software industries. , The team includes: , Jimmy ... Fund: , Roussel has a background in technology and ...
Breaking Biology Technology:Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3
... New statistics just released reveal that R&D investment in ... in 2008, an increase of 3 percent from 2007, ... Company, a San Francisco based global leader in life ... Equity, Merchant Banking and Media and the Washington DC-based ...
... March 10 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... Annual Health Care Conference on Tuesday, March 17, ... Boston. Daniel M. Bradbury, president and chief executive officer ... presentation and breakout session will be webcast, and a recording ...
... FM53 mask with its ISI developed SCBA systemBALTIMORE, March ... respiratory protection, Avon Protection Systems - a subsidiary of ... for Occupational Safety and Health) approval for its new ... division. The ST53 system combines Avon,s tactical FM53 dual ...
Cached Biology Technology:R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008 2R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008 3Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System 2Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System 3
(Date:6/1/2015)... -- According to a new market research ... (Touch-based & Touchless), Application (Consumer Electronics, Automotive, & Others), ... Global Forecast to 2020", published by MarketsandMarkets, the Gesture ... $23.55 Billion by 2020, at a CAGR of 28.23% ... market data T ables and   86   ...
(Date:6/1/2015)... 1, 2015 According to ... Market by Application (Government, Military & Defense, Healthcare, ... and Security), Technology (Face Recognition, Fingerprint Recognition, Iris ... Recognition, and Others), Function (Contact and Non-Contact) & ... Europe , APAC, Row) - Global ...
(Date:5/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ... "Facial Recognition Market by Solution, by Software, by ... 2020" report to their offering. ... technology become more efficient and cost effective. This ... investment from the commercial sector. The development of ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... sulfate supplementation before preterm delivery cuts the risk for ... by University of Alabama at Birmingham (UAB) obstetrician Dwight ... of The New England Journal of Medicine. , ... affecting control of movement and posture and limiting activity. ...
... Genetics, and working in conjunction with Society in ... exploring new avenues in the relationship between science and ... where authorship really matters. Based on a powerful authorship ... to its corresponding author. In this way readers can ...
... A 75-million-year-old fossil of a pregnant turtle and a nest ... southeastern Alberta by scientists and staff from the University of ... ideas on the evolution of egg-laying and reproduction in turtles ... of a pregnant turtle has been found and the description ...
Cached Biology News:Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 2Common treatment to delay labor decreases preterm infants' risk for cerebral palsy 3ETH Zurich-administered fund ends scientific anonymity 2Ancient mother spawns new insight on reptile reproduction 2
... Immunogen: Synthetic peptide derived from the ... 36 protein This peptide sequence is ... another Zymed polyclonal Connexin 36 antibody Cat. ... Connexin 36. Reactivity: Mouse (positive control: ...
Invitrogen's Calcium Phosphate Transfection Kit provides high-quality reagents to enable the introduction of DNA into tissue culture cells via calcium phosphate co-precipitation....
...
...
Biology Products: